Umbilical cord stem cells aim to slow muscle loss in duchenne boys
NCT ID NCT06579352
First seen Jul 21, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study tests whether stem cells from donated umbilical cords can help boys with Duchenne muscular dystrophy (DMD). The cells are given through a vein and are meant to reduce inflammation and improve muscle function. The trial includes boys aged 5 to 10 who can still walk and have stable steroid use. Researchers will track side effects and changes in movement tests and blood markers over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- human umbilical cord mesenchymal stem cells (UC-MSC) given intravenously
- What this could lead to
- If successful, this could point toward a treatment that slows muscle decline and improves daily function in Duchenne muscular dystrophy.
- What could go wrong
- This is a small, early-phase study focused on safety, so it may not show clear benefit. Stem cell treatments also carry risks like infusion reactions or unknown long-term effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neurology Rare Disease Center
Flower Mound, Texas, 75028, United States
-
Other locations - TBD
Dallas, Texas, 75201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a massive patient database unlock new treatments for muscular dystrophy?
- Experimental drug aims to preserve arm and lung function in boys with advanced duchenne
- Experimental drug KER-065 aims to slow muscle decline in duchenne muscular dystrophy
- Can early parent coaching help infants with rare genetic disorders thrive?
- Newborn screening study aims to catch rare diseases at birth
- One-Time gene infusion aims to fight duchenne muscular dystrophy